Value Based Pricing for the NHS- An Interview with NICE Chief Executive Sir Andrew Dillon
The National Institute for Health and Care Excellence (NICE) will be taking a central role in Value Based Pricing (VBP) for the NHS starting in 2014. To find out more about this, Pharma IQ spoke to NICE's Chief Executive Sir Andrew Dillon about VBP and the challenges that NICE will face in its new extended role.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.